وجد باحثو مايو كلينك أن اللقاح قد يُقلِّل من شدة أعراض كوفيد طويلة الأمد
Mayo Clinicإن تلقي لقاح كوفيد-19 قد لا يُقلِّل فقط من خطر إصابة الشخص بكوفيد طويل الأمد، ولكنه قد يعني أيضًا أعراضًا أقل للأشخاص الذين يُصابون بهذه الحالة.
إن تلقي لقاح كوفيد-19 قد لا يُقلِّل فقط من خطر إصابة الشخص بكوفيد طويل الأمد، ولكنه قد يعني أيضًا أعراضًا أقل للأشخاص الذين يُصابون بهذه الحالة.
With an uptick in COVID cases and cold and flu season approaching, health experts are warning of a possible "tripledemic". Experts from Indiana University are able to comment.
Tomar a vacina contra COVID-19 pode não só reduzir os riscos de uma pessoa contrair COVID de longa duração, mas também pode significar a redução dos sintomas para a pessoa que desenvolver a doença.
Recibir la vacuna contra la COVID-19 podría significar no solo un menor riesgo de tener síndrome crónico de COVID, sino también la presencia de menos síntomas para quienes contraigan la afección.
Although the COVID-19 pandemic was the first time most of humanity learned of the now infamous disease, the family of coronaviruses was first identified in the mid-1960s.
Grandparents appeared to serve as an important private safety net when COVID-19 first hit the U.S., according to a study led by a Washington State University researcher.
Emergency medical technicians, firefighters, and other first responders are often hailed as heroes. But many of them experience the public’s elevated perceptions of them as a form of dehumanization, which can lead to burnout, according to a new study.
A new survey from the Association for Diagnostics & Laboratory Medicine (formerly AACC) found that clinical labs’ robust, rapid response to the COVID-19 pandemic helped to contain the virus and save lives. However, the challenges labs faced with insufficient supplies and staffing shortages have only intensified since 2020. The percentage of laboratory professionals reporting staffing issues rose steadily from 35.4% in May 2020 to 87.5% in January 2022—raising questions about whether labs would have the necessary resources to respond to a similar public health emergency today.
A DNA-based vaccine is very effective at protecting against COVID-19, according to a joint preclinical study by Scancell Ltd and Texas Biomedical Research Institute (Texas Biomed) recently published in the Journal of Biotechnology and Biomedicine.
Saad B. Omer, M.B.B.S., M.P.H., Ph.D., Founding Dean of the Peter O’Donnell Jr. School of Public Health at UT Southwestern Medical Center, discovered a passion for public health while he was a medical student in Pakistan.
White-tailed deer across Ohio have been infected with the virus that causes COVID-19, new research has found – and the results also show that viral variants evolve about three times faster in deer than in humans.
Bacteria in the mouth mostly survived infection — and that’s a good thing, says a Rutgers researcher.
Findings show how storytelling narratives of individuals’ experiences often leave out broader public health, socioeconomic and environmental contexts, which can be crucial for building empathy and influencing policy decisions.
SCALE-UP Counts was designed to promote COVID-19 testing in local schools. Huntsman Cancer Insitute’s Yelena Wu, PhD, hopes the insight gained from the program improves cancer screening and education initiatives.
Voluntary collective isolation alone was ineffective to mitigate the spread of COVID-19 into small-scale, remote Indigenous communities of the Tsimané in the Bolivian Amazon.
Keck Medicine of USC experts discuss new recommendations for staying healthy and safe during the respiratory virus season
Millions of Americans were exposed to SARS-CoV-2, the virus that causes COVID-19, early in the pandemic but could not get diagnosed due to testing limitations. Many of those people developed a post-viral syndrome with symptoms similar to those of long COVID.
High levels of exposure to the virus that causes COVID-19 may reduce or overcome the protection that vaccination and prior infection provides, according to a new study.
Bus drivers were at double the risk of being hospitalized for severe COVID-19 in the later stages of the pandemic, and several occupations in education and healthcare were also at risk of serious illness.
Getting a COVID-19 vaccine may not only reduce a person's risk of getting long-haul COVID, but also could mean fewer symptoms for people who develop the condition.
New research has identified which people with compromised immune systems are less likely to have COVID-19 antibodies - making them more vulnerable to a severe infection.
While COVID-19 lockdowns are no longer mandated, the stress and anxiety of the pandemic still lingers, especially among young South Australians, say health experts at the University of South Australia.
Severe COVID-19 may cause long-lasting alterations to the innate immune system, the first line of defense against pathogens, according to a small study funded by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.
A Murdoch Children’s Research Institute-led review has found COVID-19 vaccines are effective against severe cases of the disease in children and adolescents.
An analysis of more than 45,000 people infected with SARS-CoV-2 found a significant association between the virus and the development of persistent high blood pressure among those with no prior history of high blood pressure.
Researchers at McMaster University have found that rather than conferring immunity against future infections, infection during the first Omicron wave of COVID left the seniors they studied much more vulnerable to reinfection during the second Omicron wave.
A two-year study found that spikes of post-vaccination SARS-CoV-2 viral infections (commonly known as COVID-19 breakthrough cases) remain common, yet hospitalization rates have dramatically dropped following the first wave of the virus’ omicron subvariant.
A new study from researchers at Michigan State University and Tilburg University found that Americans’ political attitudes did not change significantly during the onset of the COVID-19 pandemic, contrary to what many expected. Mark Brandt, a researcher and associate professor of psychology at MSU, shares what these findings could mean.
Smell loss became the cardinal symptom of COVID-19 early in the pandemic and has ignited research on how smell and taste function. An international study led by the Global Consortium for Chemosensory Research (GCCR) and the Monell Chemical Senses Center has untied taste from smell in people with COVID-19, demonstrating in a large and diverse group of more than 10,000 people that taste, independent of smell, is also greatly impacted by COVID.
Exposure to common cold-causing coronaviruses may contribute to pre-existing immunity to COVID-19, according to a new study involving a Rutgers research scientist.
A new method to assess the status of immune responses to specific antigens in detail by analysis using the B cell receptor (BCR) repertoire(*1) has been developed by a research group.
Nurses’ intentions to leave nursing increased during the COVID-19 pandemic, a recent study from the University of Eastern Finland shows. Yet, nurses estimated their resilience to be high.
Variety of health back to school pitches from the experts at Hackensack Meridian Children's Health
It’s an idea that has finally gained scientific consensus: Dogs can be a faster, more precise, less expensive — not to mention friendlier — method of detecting COVID-19 than even our best current technology.
As the virus that caused the COVID-19 pandemic first began to spread around the planet, it brought along a new vocabulary. Unfamiliar phrases like “flatten the curve,” “COVID pod” and “essential worker” infected regular conversation. But another — “do your own research” — was already well-known to Sedona Chinn, who studies misinformation and health communications.
La inteligencia artificial (IA) está capturando la imaginación del público a medida que el ritmo de la innovación se acelera considerablemente y las herramientas de IA fáciles de usar ofrecen nuevas posibilidades para transformar industrias enteras.
A new study by UC Berkeley Anthropology Professor Andrew Wooyoung Kim reveals resilient coping mechanisms used by healthcare workers during the COVID-19 pandemic in metro Johannesburg, South Africa.
Most people in Canada now have hybrid immunity against SARS-CoV-2 through a mix of infection and vaccination, new research in CMAJ (Canadian Medical Association Journal) shows.
Researchers at Rutgers Cancer Institute of New Jersey and Rutgers New Jersey Medical School (NJMS), together with other collaborating groups, have discovered the first lipid vascular ‘ZIP code’ in the lungs, with implications for improved diagnostics and treatments, including patients with severe human respiratory diseases such as emphysema, COVID-19, COPD and lung cancer.
Unexpected new insights into how COVID-19 infects cells may help explain why coronaviruses are so good at jumping from species to species and will help scientists better predict how COVID-19 will evolve.
An unusual case of a Long Covid patient’s legs turning blue after 10 minutes of standing highlights the need for greater awareness of this symptom among people with the condition, according to new research published in the Lancet.
Artificial intelligence (AI) is capturing the public imagination as the pace of innovation accelerates sharply and easy-to-use AI tools offer new possibilities to transform whole industries.
Researchers at The Jackson Laboratory have created a panel of genetically diverse mice that accurately model the highly variable human response to SARS-CoV-2 infection.
The recent discontinuation of pandemic-related food assistance benefits, known as the Supplemental Food Assistance Program (SNAP) Emergency Allotments, led to a substantial increase in food insufficiency in the United States, according to a new study led by researchers at the Perelman School of Medicine at the University of Pennsylvania.
This summer, like every summer since COVID-19 arrived on the scene, the U.S. is experiencing a spike in infections and hospitalizations.
What causes long COVID? More than three years after the start of the pandemic, this remains the most bedeviling question about a mystifying syndrome estimated to affect some 65 million people globally — an epidemic in its own right with no clear end in sight.
Researchers demonstrate that among individuals who were admitted to the hospital with COVID-19 and were discharged alive, the risk of post-discharge death was nearly twice that observed in those who were discharged alive from an influenza-related hospital admission.